Verve Therapeutics Inc.
Verve Therapeutics Inc.
World Rank (Jan-05-2024)
8,130
Market Cap (Jan-05-2024)
1.095 Billion USD
World Rank (Jul-30-2023)
7,713
Market Cap (Jul-30-2023)
1.232 Billion USD
World Rank (Jan-07-2022)
7,318
Market Cap (Jan-07-2022)
1.544 Billion USD
Headquarters Country
Nasdaq / NYSE Code
VERV
Annual Revenue in USD
2 Million USD
Annual Net Income in USD
-157 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
679 Million USD
Total Liabilities in USD
128 Million USD
Total Equity in USD
550 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Company Website
Ads